{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:34:27Z","timestamp":1763051667018,"version":"3.45.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.1182\/blood.2025030661","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:31:39Z","timestamp":1763051499000},"page":"2375-2377","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Asparaginase rechallenge after pancreatitis: pain or gain?"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6603","authenticated-orcid":false,"given":"Rachel E.","family":"Rau","sequence":"first","affiliation":[{"name":"University of Washington"},{"name":"Seattle Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"20","key":"2025111311313202800_bib1","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.2025029785","article-title":"Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL","volume":"146","author":"Chen","year":"2025","journal-title":"Blood"},{"issue":"12","key":"2025111311313202800_bib2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1097-0142(196612)19:12<1813::AID-CNCR2820191208>3.0.CO;2-E","article-title":"Toxic and antineoplastic effects of l-asparaginase: study of mice with lymphoma and normal monkeys and report on a child with leukemia","volume":"19","author":"Dolowy","year":"1966","journal-title":"Cancer"},{"issue":"9","key":"2025111311313202800_bib3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S1470-2045(17)30424-2","article-title":"Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study","volume":"18","author":"Wolthers","year":"2017","journal-title":"Lancet Oncol"},{"issue":"17","key":"2025111311313202800_bib4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"17","key":"2025111311313202800_bib5","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood.2020006583","article-title":"Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia","volume":"137","author":"Gottschalk H\u00f8jfeldt","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2025111311313202800_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.25489","article-title":"L-asparaginase treatment in acute lymphoblastic leukemia","volume":"117","author":"Pieters","year":"2011","journal-title":"Cancer"},{"issue":"17","key":"2025111311313202800_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"2025111311313202800_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"2025111311313202800_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"2025111311313202800_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1200\/JCO.23.01392","article-title":"Blinatumomab for first-line treatment of children and young persons with B-ALL","volume":"42","author":"Hodder","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/20\/2375\/2419998\/blood_bld-2025-030661-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/20\/2375\/2419998\/blood_bld-2025-030661-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:31:41Z","timestamp":1763051501000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/20\/2375\/548049\/Asparaginase-rechallenge-after-pancreatitis-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":10,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,11,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025030661","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,13]]},"published":{"date-parts":[[2025,11,13]]}}}